Episode 15: Cancer Immunotherapy Trends to Impact Patients and R&D
Mar 18, 2020
23:05
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Today’s episode features a conversation with Dr. Tatiana Novobrantseva, Co-Founder and CSO of Verseau Therapeutics. In this interview, we discuss five trends in the development of cancer immunotherapies and how these will impact patients and biopharmaceutical research and development.
The Chain: Protein Engineering Podcast